Abingdon Health Statistics
Total Valuation
Abingdon Health has a market cap or net worth of GBP 26.32 million. The enterprise value is 23.65 million.
Market Cap | 26.32M |
Enterprise Value | 23.65M |
Important Dates
The last earnings date was Friday, June 20, 2025.
Earnings Date | Jun 20, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Abingdon Health has 375.95 million shares outstanding. The number of shares has increased by 8.55% in one year.
Current Share Class | 193.63M |
Shares Outstanding | 375.95M |
Shares Change (YoY) | +8.55% |
Shares Change (QoQ) | +16.11% |
Owned by Insiders (%) | 7.23% |
Owned by Institutions (%) | 33.61% |
Float | 135.52M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 3.86 |
PB Ratio | 4.10 |
P/TBV Ratio | 7.33 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -9.14 |
EV / Sales | 3.47 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -8.84 |
Financial Position
The company has a current ratio of 2.55, with a Debt / Equity ratio of 0.16.
Current Ratio | 2.55 |
Quick Ratio | 2.36 |
Debt / Equity | 0.16 |
Debt / EBITDA | n/a |
Debt / FCF | -0.38 |
Interest Coverage | -39.55 |
Financial Efficiency
Return on equity (ROE) is -62.83% and return on invested capital (ROIC) is -28.93%.
Return on Equity (ROE) | -62.83% |
Return on Assets (ROA) | -20.26% |
Return on Invested Capital (ROIC) | -28.93% |
Return on Capital Employed (ROCE) | -32.09% |
Revenue Per Employee | 60,345 |
Profits Per Employee | -22,894 |
Employee Count | 84 |
Asset Turnover | 0.93 |
Inventory Turnover | 7.56 |
Taxes
Income Tax | -225,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -32.24% in the last 52 weeks. The beta is 0.22, so Abingdon Health's price volatility has been lower than the market average.
Beta (5Y) | 0.22 |
52-Week Price Change | -32.24% |
50-Day Moving Average | 6.41 |
200-Day Moving Average | 7.45 |
Relative Strength Index (RSI) | 42.40 |
Average Volume (20 Days) | 83,373 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Abingdon Health had revenue of GBP 6.82 million and -2.59 million in losses. Loss per share was -0.01.
Revenue | 6.82M |
Gross Profit | 3.59M |
Operating Income | -2.37M |
Pretax Income | -2.81M |
Net Income | -2.59M |
EBITDA | -2.03M |
EBIT | -2.37M |
Loss Per Share | -0.01 |
Balance Sheet
The company has 3.67 million in cash and 1.01 million in debt, giving a net cash position of 2.66 million or 0.01 per share.
Cash & Cash Equivalents | 3.67M |
Total Debt | 1.01M |
Net Cash | 2.66M |
Net Cash Per Share | 0.01 |
Equity (Book Value) | 6.42M |
Book Value Per Share | 0.02 |
Working Capital | 3.75M |
Cash Flow
In the last 12 months, operating cash flow was -2.65 million and capital expenditures -23,000, giving a free cash flow of -2.68 million.
Operating Cash Flow | -2.65M |
Capital Expenditures | -23,000 |
Free Cash Flow | -2.68M |
FCF Per Share | -0.01 |
Margins
Gross margin is 52.57%, with operating and profit margins of -34.80% and -37.94%.
Gross Margin | 52.57% |
Operating Margin | -34.80% |
Pretax Margin | -41.24% |
Profit Margin | -37.94% |
EBITDA Margin | -29.83% |
EBIT Margin | -34.80% |
FCF Margin | n/a |
Dividends & Yields
Abingdon Health does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -8.55% |
Shareholder Yield | n/a |
Earnings Yield | -9.83% |
FCF Yield | -10.17% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Abingdon Health has an Altman Z-Score of 1.46 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.46 |
Piotroski F-Score | 2 |